DRL launched four new products in North America during the previous quarter.
Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Motherson Sumi, Tata Steel, Jaguar Land Rover will face higher cost.
Dr Reddy's gets warning from US health regulator
Of the 294 candidates declared with serious criminal cases, 76 were from the TMC, 52 from the BJP, 47 from the CPI-M and 31 from the Congress.
The BJP could win only 16 out of 57 seats where Shah campaigned.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances